Calciumantagonisten bei organischen und funktionellen peripheren Durchblutungsstörungen

  • C. Diehm
  • E. Hsu


Im Folgenden werden Epidemiologie, Klinik, Diagnose und Pathophysiologie der PAVK, Thrombangiitis obliterans, Akrozyanose, des RaynaudPhänomens, Ergotismus, Blue-toe-Phänomens, von Frostbeulen und Erfrierungen ausführlich im Hinblick auf eine Therapie der jeweiligen Erkrankung mit Calciumantagonisten beschrieben.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aldoori, M, Campbell, WB, Dieppe, PA (1986) Nifedipine in the treatment of Raynaud’s Syndrome. Cardiovascular Research 20 (6): 466-470PubMedCrossRefGoogle Scholar
  2. 2.
    Allen, EV, Brown, GE (1932) Raynaud’s disease: a critical review of minimal requisites for diagnosis. American Journal of Medical Sciences 183: 183-187CrossRefGoogle Scholar
  3. 3.
    Alpert MA, Pressly TA, Mukerji, V, Lampbert, CR, Mukerji, B, Panayiotou, H, Sharp GC (1991) Acute and long term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. American Journal of Cardiology 68 (17): 1687-1691PubMedCrossRefGoogle Scholar
  4. 4.
    Amabile, G, Serradimigni, A (1987) Study of nicardipine in moderate hypertension and its influence on lipid metabolism. Pract Med 26: 41-42Google Scholar
  5. 5.
    Andersen, LB, Thestrup-Pedersen, K, Sell, A (1988) Nifedipine treatment of Raynaud’s phenomenon secondary to chemotherapy. Dermatologica 177 (1): 19-20PubMedCrossRefGoogle Scholar
  6. 6.
    Antti-Poika I, Pohjolainen T, Alaranta H (1990) Severe frostbite of the upper extremities — a psychosocial problem mostly associated with alcohol abuse [see comments] Scand-J-SocMed. 18 (1): 59-61Google Scholar
  7. 7.
    Anttonen H (1993) Occupational needs and evaluation methods for cold protective clothing. Arctic-Med-Res. 52 (Suppl 9): 1-76PubMedGoogle Scholar
  8. 8.
    Arbeitsgruppe Sklerodermie (1986) Klinik der progressiven systemischen Sklerodermie. Hautarzt 37: 320Google Scholar
  9. 9.
    Bernardi D, Bartoli P, Ferreri A, Geri AB, Leri A (1988) Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound. Angiology 39 (11): 942-952PubMedCrossRefGoogle Scholar
  10. 10.
    Beeley JM, Smith DJ, Oakley EH (1993) Environmental hazards and health. Br-MedBull 49 (2): 305-325Google Scholar
  11. 11.
    Belcaro G, Nicholaides AN (1989) Microvascular evaluation of the effect of nifedipine in vascular patients by laser-Doppler flowmetry. Angiology 40 (8): 689-694PubMedCrossRefGoogle Scholar
  12. 12.
    Beykirch H, Reuter W, Voigt H, Herrmann W (1989) Lipidstoffwechsel and periphere Hämodynamik bei Arteriosclerosis obliterans unter Nifedipin. Zeitschrift für die gesamte Innere Medizin and ihre Grenzgebiete, 44 (3): 77-79Google Scholar
  13. 13.
    Brotzu G, Falchi S, Mannu B, Montisci R, Petruzzo P, Staico R (1989) The importance of presynaptic beta receptors in Raynaud’s disease. Journal of vascular surgery 9 (6): 767-771PubMedGoogle Scholar
  14. 14.
    Bursztyn M, Grossman E, Rosenthal T (1985) Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases. American Heart Journal 110 (1): 96-101PubMedCrossRefGoogle Scholar
  15. 15.
    Chacon-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Munoz I, Concha M (1994) Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs. Angiology 45 (7): 647-653PubMedCrossRefGoogle Scholar
  16. 16.
    Challenor VF, Waller DG, Hayward RA, Griffin MJ, Roath OS (1989) Vibrotactile sensation and response to nifedipine dose titration in primary Raynaud’s phenomenon. Angiology 40 (2): 122-128PubMedCrossRefGoogle Scholar
  17. 17.
    Controlled multicenter double-blind trial of nicardipine in the treatment of primary Raynaud phenomenon (1991). French Cooperative Multicenter Group for Raynaud phenomenon, Paris, Franc. American Heart Journal 122 (2): 352-355Google Scholar
  18. 18.
    Crouch C, Smith WL (1990) Long term sequelae of frostbite. Pediatr-Radiol. 20 (5): 365-366PubMedCrossRefGoogle Scholar
  19. 19.
    Diehm C, Müller-Bühl U, Mechtersheimer U, Mörl H (1984) Lokale Isosorbitdinitrat-Salbenbehandlung beim Rauynaud-Phänomen. Vasa 13: 72-74PubMedGoogle Scholar
  20. 20.
    Diehm C, Müller-Bühl U (eds) (1991) Angiologie — Praxis der Gefäßkrankheiten, W. Kohlhammer, Stuttgart, Berlin, KölnGoogle Scholar
  21. 21.
    Diehm C, Weiss T (eds) (1995) Die periphere arterielle Verschlußkrankheit, Lingua Med, Neu IsenburgGoogle Scholar
  22. 22.
    Diehm C, Schäfer M (eds) (1993) Das Buerger-Syndrom — Thrombangiitis obliterans. Springer, Berlin, HeidelbergGoogle Scholar
  23. 23.
    Fisher M, Grotta J (1993) New uses for calcium channel blockers. Therapeutic implications. Drugs 46 (6): 961-975PubMedCrossRefGoogle Scholar
  24. 24.
    Frey M, Just H (1994) Role of calcium antagonists in progression of arteriosclerosis: Evidence from animal experiments and clinical experience. Part I. Preventive effects of calcium antagonists in animal experiments. Basic res cardiol suppl 89 (1): 161-176Google Scholar
  25. 25.
    Goette DK (1990 Aug) Chilblains (perniosis). J-Am-Acad-Dermatol. 23 (1): 257-262PubMedCrossRefGoogle Scholar
  26. 26.
    Greer IA (1987) Therapeutic progress-review XXVIII. Platelet function and calcium channel blocking agents. Journal of Clinical Pharmacology and Therapeutics 12 (4): 213-222CrossRefGoogle Scholar
  27. 27.
    Grodzinska L, Basista M, Basista E, Slawinski M, Swies J, Stachura J, Ohlrogge R (1987) Nitrendipine stimulated release of prostacyclin-like substance in normal and atherosclerotic animals. Arzneimittel Forschung 37 (4): 412-415PubMedGoogle Scholar
  28. 28.
    Groechenig E (1994 Oct 22) Treatment of frostbite with iloprost [letter] Lancet. 344 (8930): 1152-1153Google Scholar
  29. 29.
    Grün G, Byon KY, Tritthart HA, Fleckenstein A (1970) Inhibition of automaticity and contractility of isolated human uterine muscle by Ca-antagonistic compounds. Pfliigers Arch Eur J Physiol 319; 118Google Scholar
  30. 30.
    Harvey CK (1992) An overview of cold injuries. J Am Podiatr Med Assoc. 82 (8): 436-438PubMedGoogle Scholar
  31. 31.
    Helzer-Julin M (1994) Sun, heat, and cold injuries in cyclists. Clin-Sports-Med 13 (1): 219-234PubMedGoogle Scholar
  32. 32.
    Hiramatsu K, Yamagishi F, Kubota T, Yamada T (1982) Acute effect of the calcium antagonist nifedipine on blood pressure, pulse rate, and the renin-angiotensin-aldosterone system in patients with essential hypertension. Am Heart J 104: 1346-1350PubMedCrossRefGoogle Scholar
  33. 33.
    Kannel WB, Skinner JR, Schwartz MJ, Shurtleff D (1970) Intermittent claudication: Incidence in the Framingham Study. Circulation 41: 875-883PubMedGoogle Scholar
  34. 34.
    Kimose HH, Bagger JP, Aagard MT, Paulsen PK (1990) Placebo-controlled, double-blind study of the effect of verapamil in intermittent claudication. Angiology 41 (8): 895-898Google Scholar
  35. 35.
    Lacoste L et al. (1994) Oral verapamil inhibits platelet Thrombus formation in Humans. Circulation 89: 630-634Google Scholar
  36. 36.
    Lewis P, Psaila JV, Davies WT, Morgan RH, Woodcock JP (1989) Nifedipine in patients with peripheral vascular disease. European Journal of Vascular Surgery 3 (2): 159-164PubMedCrossRefGoogle Scholar
  37. 37.
    Malinow MR (1981) Regression of atherosclerosis in humans: Fact or myth Circulation 64: 1-3PubMedGoogle Scholar
  38. 38.
    Marshall M (1988) Moderne Therapie der arteriellen Verschlußkrankheit. Perfusion 1: 920Google Scholar
  39. 39.
    McCauley RL, Heggers JP, Robson MC (1990) Frostbite. Methods to minimize tissue loss. Postgrad-Med. 88 (8): 67-68, 73-77Google Scholar
  40. 40.
    Mills WJ Jr, O’Malley J, Kappes B (1993) Cold and freezing: a historical chronology of laboratory investigation and clinical experience. Alaska-Med. 35 (1): 89-116PubMedGoogle Scholar
  41. 41.
    Nobbe F (1980) Erkrankungen durch Kälte oder Hitze. In: Rebentisch, E (Hrsg.) Wehrmedizin. Urban and Schwarzenberg, München, Baltimore, pp. 39.Google Scholar
  42. 42.
    Pola P, Savi L (1978) Peripheral vascular dynamics studied by calcium ion inhibition. Angiology 29 (7): 506-519PubMedCrossRefGoogle Scholar
  43. 43.
    Revuz J (1992) Cutaneous pathology induced by cold Ann-Dermatol-Venereol. 119 (67): 455-456, 1992Google Scholar
  44. 44.
    Rosen L, Eltvik L, Arvesen A, Stranden E (1991) Local cold injuries sustained during military service in the Norwegian Army. Arctic-Med-Res. 50 (4): 159-165PubMedGoogle Scholar
  45. 45.
    Russel JD, Churchill DN (1989) Calcium antagonists and acute renal failure. American Journal of Medicine 87 (3): 306-315CrossRefGoogle Scholar
  46. 46.
    Saito S, Shimada H (1994) Effect of prostaglandin El analogue administration on peripheral skin temperature at high altitude. Angiology. 45 (6): 455-460PubMedCrossRefGoogle Scholar
  47. 47.
    Schmidt JF, Valentin N, Nielsen SL (1989) The clinical effect of felodipine and nifedipine in Raynaud’s phenomenon. European Journal of Clinical Pharmacology 37 (2): 191-192PubMedCrossRefGoogle Scholar
  48. 48.
    Schmitz G, Hankowitz J, Kovacs EM (1991) Cellular processes in atherosclerosis: potential targets of Ca’ channel blockers. Atherosclerosis 88 (3): 109-132PubMedCrossRefGoogle Scholar
  49. 49.
    Schrub JC, Doucet J, Gancel A, Ozenne G, Vuillermet P (1988) Insulin secretion and nicardipine: study in nine non-insulin-dependent diabetics. Sem. Hopital Paris 64 (16): 1087-1090Google Scholar
  50. 50.
    Skolnick AA (1992) Early data suggest clot-dissolving drug may help save frostbitten limbs from amputation [news] JAMA. 267 (15): 2008-2010, 1992Google Scholar
  51. 51.
    Spittell JA (1980) Vascular syndromes related to environmental temperature. In Juergens JL, Spittell JA, Fairburn NJ (eds) Peripheral Vascular Disease. Philadelphia, WB Saunders Co, pp. 585-607Google Scholar
  52. 52.
    Sowers JR (1992) Antiatherosclerotic effect of calcium channel blockers. Postgraduate Medicine 92 (2): 265-268PubMedGoogle Scholar
  53. 53.
    Taylor MS (1992) Cold weather injuries during peacetime military training. Mil-Med. 157 (11): 602-604, 1992PubMedGoogle Scholar
  54. 54.
    Thiery J, Niedmann PD, Seidel D (1987) The beneficial influence of nifedipine on the regression of the cholesterol-induced atherosclerosis in rabbits. Research in Experimental Medicine 187 (5): 359-367PubMedCrossRefGoogle Scholar
  55. 55.
    Urschel JD (1990) Frostbite: predisposing factors and predictors of poor outcome. J-Trauma. 30 (3): 340-342PubMedCrossRefGoogle Scholar
  56. 56.
    Virokannas H, Anttonen H (1993) Risk of frostbite in vibration-induced white finger cases. Arctic-Med-Res. 52 (2): 69-72PubMedGoogle Scholar
  57. 57.
    Widmer LK, Stähelin HB, Nissen C, Da Silva A (1981) Venen-, Arterienkrankheiten, koronare Herzkrankheit bei Beruftätigen. Huber, Bern/Stuttgart/WienGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG, Darmstadt 1996

Authors and Affiliations

  • C. Diehm
  • E. Hsu

There are no affiliations available

Personalised recommendations